• The Problem: Gadolinium, a metal used in dye for contrasting MRI procedures, allegedly causes serious brain injuries in patients who have had numerous MRIs.

  • The Response: Two lawsuits were filed in 2016 and the FDA has issued warnings and new medication guidelines.

  • What Can We Do to Help: Our experienced attorneys can review your medical records and advise you if filing a case is in your best interest. 

The attorneys at Gallon, Takacs & Boissoneault are investigating allegations that Gadolinium, a dye used in Contrasting MRIs, can cause  itching or pain in skin,overwhelming joint pain, brain fog and confusion, severe headaches and kidney damage.If you or someone you know developed any of these symptoms after undergoing a Contrasting Dye MRI, contact us today. Find out if you can seek compensation for your injuries by completing our free case evaluation.


Gadolinium can stay in the body for months or even years potentially causing bone and joint pain, burning sensations and brain fog.

Gadolinium is an element in nature that has been used for many years as an ingredient in dye used for Contrasting MRIs. By giving clearer images, it can help physicians diagnose tumors, inflammation, blood clots and more medical conditions. The common use of MRIs as a diagnostic tool has increased the exposure to Gadolinium for patients, and with many patients numerous times. The contrasting agent is administered through an IV.

There are eight brands of gadolinium-based contrast agents (GBCAs) available in the U.S., including Omniscan, Magnevist and OptiMARK. Gadolinium retention is greater with Omniscan (gadodiamide) and Optimark (gadoversetamide) than with Eovist (gadoxetate disodium), Magnevist (gadopentetate dimeglumine) and MultiHance (gadobenate dimeglumine).

The FDA issued an updated warning on the retention of Gadolinium in the body May 16, 2018, following the original packaging  and classification changes ordered December 19, 2017.

Some of the symptoms may appear immediately or show up over time. Gadolinium is found to stay longer in the bones.

Symptoms can include:

  • Pain – aching; burning, tingling, and/or prickling pain (paresthesia); deep bone pain.  It can occur in bones and joint or at the injection site of the agen.
  • Dermal changes – like tight skin, lesions, hyperpigmentation.  Most often in extremities.
  • Muscle issues – twitching – small, local, rapid contractions and weakness
  • Ocular problems – worsening vision,  dry eyes, bloodshot eyes
  • Cognitive symptoms – confusion, brain fog
  • Ear, nose and throat – tinnitus, swallowing, and voice problems
  • Low body temperature
  • Hair loss
  • Itchy skin
  • Balance problems
  • Swelling of extremities (edema)

No class action suits or MDLs have been established. The concerns about Gadolinium are ongoing. If you or a loved one have experienced any of these symptoms following a Contrasting MRI, please contact our firm at 1-800-Gallon1 (1-800-425-5661) or fill out a free case evaluation form. We want to help you get the compensation you deserve.